Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05767749Phase 4Completed
Phase 4, randomised, double-blind trial in procedural pain comparing Lidocaine + epinephrine vs Ropivacaine, Lidocaine + epinephrine vs Bupivacaine and Ropivacaine vs Bupivacaine (3 arms). Primary endpoint: Time to Return to Baseline Sensation up to 4 hours. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05767749.